Physician profile
William C Stych
NPI 1386746808
$6,384.73
in general payments reported to CMS, 2019-2025
24 companies · $629 in 2025
The $629 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $319 · 2021: $347 · 2022: $2,019 · 2023: $1,064 · 2024: $1,235 · 2025: $629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,760 · Education: $169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,759.51 |
| Education | $168.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,418.02 | 2019-2025 | Affinity, Apligraf, Via Matrix |
| Paragon 28, INC. | $640.11 | 2019-2024 | Portfolio, Grappler, Paratrooper |
| Stryker Corporation | $609.12 | 2022-2025 | Citrefix, Phalinx, Augment Injectable |
| Convatec INC. | $510.40 | 2023-2025 | |
| Smith+Nephew, INC. | $380.48 | 2019-2024 | Pico, Healicoil, Q-Fix |
| Integra Lifesciences Corporation | $372.16 | 2021-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Medline Industries Lp | $329.49 | 2022-2023 | |
| Cardiovascular Systems INC. | $257.79 | 2019-2022 | |
| Amgen INC. | $248.55 | 2024-2025 | Krystexxa |
| Bard Peripheral Vascular, INC. | $229.74 | 2022 | |
| Kerecis Limited | $192.50 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Horizon Therapeutics Plc | $188.65 | 2022-2023 | Krystexxa |
| Linvatec Corporation | $177.75 | 2023 | Fracture and Correction Colag 2, Colink Plating System, Colink Vallux |
| Inari Medical, INC. | $144.29 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Treace Medical Concepts, INC. | $138.00 | 2023 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $125.40 | 2022-2023 | Diamondback Coronary |
| Wright Medical Technology, INC. | $122.28 | 2019 | |
| Depuy Synthes Sales INC. | $86.06 | 2022 | |
| Acera Surgical, INC. | $69.28 | 2022 | |
| Mimedx Group, INC. | $46.89 | 2025 | |
| Abbvie INC. | $30.29 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $27.03 | 2022 | |
| Medtronic Vascular, INC. | $20.81 | 2020 | |
| Bioventus LLC | $19.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stych listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.